1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Buzón-Martín L, Montes ML, Pedrero R, Galindo MJ, Santacreu-Guerrero M, Alemán MR, Torralba M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello A, Crusells MJ, Navarro MDC, Aguilera M, Hidalgo-Tenorio C, Morano-Amado LE, Vinuesa D, De Andres C, Bernal-Morell E, Martínez-Álvarez RM, Cabello-Clotet N, Tiraboschi J, Montero MDC, Vivancos-Gallego MJ, Díez C, Calderón R, De Zárraga MA, Gisbert L, Romero-Palacios A, Cabo R, Soler JF, Sepúlveda MA, Sánchez-Guirao AJ, Escrich C, Arnaiz De Las Revillas F, Ferreira E, Valentín B, Lérida A, Llenas-García J, Gómez A, Losa JE, Alonso B, Sanz J, Masiá M, Pernas H, Corte JJ, Garcinuño MÁ, Gainzarain JC, Estébanez M, García-Navarro MDM, Barragán P, Ramos N, Clavero M, Millán M, Del Álamo M, Egido M, De La Calle B, Ferrero OL, Troya J.

    A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 80(12): 3438-3451. Nº de citas: 5

    [doi:10.1093/jac/dkaf389]

  • Casado JL, Blanco JL, Izuzquiza I, Moreno A, Vizcarra P, Vallejo A.

    From TRIO to one: simplification to bictegravir/emtricitabine/tenofovir alafenamide in highly treatment-experienced people living with MDR HIV

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 80(12): 3242-3247. Nº de citas: 1

    [doi:10.1093/jac/dkaf357]

  • Espinosa-Del-Barrio L, Gómez G de la Pedrosa E, Álvarez-Díaz N, Guzmán Martínez J, Corbacho Loarte MD, Escudero Sánchez R, Martín-Dávila P, Fortún Abete J, Cobo Reinoso J, Pintado García V, Gioia F.

    Aspergillus Endocarditis in Native Valves in Non-Traditional Hosts: A Systematic Review of a Case in a Patient with CREST Syndrome and Advanced Liver Cirrhosis.

    Journal of Fungi . 11(12): . Nº de citas: 1

    [doi:10.3390/jof11120836]

  • Escudero-Sanchez R, Morata L, Buzón L, de la Villa S, Rico A, Nuñez Orantos MJ, Guio Carrion L, Tasias Pitarch M, Del Pozo JL, Barbero JM, Gómez-Junyent J, García Pais MJ, Bachiller Luque P, Martínez Marcos FJ, Cobo J, Geio Spanish Group For Osteoarticular Infections.

    Dalbavancin as Suppressive Therapy for Implant-Associated Osteoarticular Infections

    Antibiotics-Basel . 14(11): .

    [doi:10.3390/antibiotics14111171]

  • Pascucci D, Nicolàs A, Taha A, Lazarus JV, Di Pumpo M, Tricomi V, Di Berardino F, La Vecchia C, Perez-Molina JA, Colucci G, Picchio CA, Pezzullo AM, Boccia S.

    Monitoring and evaluation of community interventions for viral hepatitis among migrants and refugees: a Delphi-based study

    Journal of Global Health . 15: 4335-4335.

    [doi:10.7189/jogh.15.04335]

  • Casado JL, Vizcarra P, Martín-Hondarza A, Moreno A, Pérez-Elías MJ, Fernández-Chica C, Martín-Colmenarejo S, Vallejo A.

    Humoral and cellular immune responses in people living with HIV following successive COVID-19 vaccine booster doses.

    CLINICAL MICROBIOLOGY AND INFECTION . 31(11): 1855-1864. Nº de citas: 2

    [doi:10.1016/j.cmi.2025.06.007]

  • Maertens JA, Thompson GR 3rd, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M, Morrissey CO, Mehta SR, Heath CH, Koehler P, Paterson DL, Slavin MA, Fortún J, Nguyen MH, Patterson TF, Uspenskaya O, Van de Veerdonk FL, Verweij PE, Aoun M, Georgala A, Alexander BD, Chayakulkeeree M, Mehra V, Miceli MH, Sikka MK, Solé A, Walsh TJ, Aguado JM, Holland SM, Moussa M, Rautemaa-Richardson R, Bazaz R, Schwartz S, Walsh SR, Plate M, Yehudai-Ofir D, Brüggemann RJ, Cornely OA, Ostrosky-Zeichner L, Vazquez JA, White PL, Cornelissen K, Ross GG, Fitton L, Dane A, Zinzi D, Rex JH, Chen SC.

    Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

    LANCET INFECTIOUS DISEASES . 25(11): 1177-1188. Nº de citas: 20

    [doi:10.1016/S1473-3099(25)00224-5]

  • Gayoso Cantero D, Corbacho Loarte MD, Monge Maillo B.

    Diagnostic delay in Strongyloides stercoralis infections.

    MEDICINA CLINICA . 165(5): 107123-107123.

    [doi:10.1016/j.medcli.2025.107123]

  • Behrens GMN, Assoumou L, De Wit S, MacDonald R, de Castro N, Rokx C, Middleditch H, Johnson M, Casado JL, Arribas JR, Blanco JR, Fletcher C, Eteve-Pitsaer C, Baldé A, Pozniak A, Martinez E.

    Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control study

    HIV MEDICINE . 26(11): 1657-1672.

    [doi:10.1111/hiv.70094]

  • Gayoso Cantero D, Fernández-González P, Chamorro-Tojeiro S, Quereda C, Tato M, Berna-Rico E, Naharro-Rodríguez J, Perez-Molina JA.

    Clinical, therapeutic, and stigma-related challenges in leprosy and the emerging role of apremilast in managing leprosy reactions

    Travel Medicine and Infectious Disease . 68: 102918-102918.

    [doi:10.1016/j.tmaid.2025.102918]

  • Díaz-García C, Serrano-Villar S, G García-Ruiz de Morales A, Güerri-Fernández R, Pérez-Somarriba J, Sánchez Palomino S, Suárez-García I, Hernández Gutiérrez C, Dalmau Juanola D, Moreno S, Moreno E, Martínez-Sanz J.

    Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment

    Open Forum Infectious Diseases . 12(11): . Nº de citas: 1

    [doi:10.1093/ofid/ofaf626]

  • Velasco M, Flores-Chávez MD, Llenas-García J, García Rodríguez M, García Vázquez E, López-Medrano F, Len O, Esperalba Esquerra J, Martínez Pérez Á, Díaz-Menéndez M, Moure García Z, Pérez Ayala A, Rodríguez Guardado A, Albasanz Puig A, Alguacil M, Álvarez-Martínez MJ, Arsuaga Vicente M, Belhassen Garcia M, Buitrago MJ, Calabuig E, de la Calle F, Dopico E, Fernández-Ruiz M, Gudiol C, Herrero-Martínez JM, Lozano Serrano AB, Martin O, Martín-Dávila P, de Miguel R, Muelas Fernández M, Navarro Beltrá M, Norman FF, Palacios Gutiérrez JJ, Pérez-Jacoiste A, Rodríguez-Sevilla G, Rodríguez Zúñiga D, Salvador F, Sánchez Montalvá A, Seral C, Vázquez González A, Wikman Jorgensen PE, Sulleiro Igual E.

    Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC: GEPI, GeSIDA, GESITRA-IC, GEIRAS) on screening for imported infectious diseases in immunocompromised patients.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 43(9): 611-615. Nº de citas: 2

    [doi:10.1016/j.eimce.2025.07.005]

  • Isla D, Zugazagoitia J, Arriola E, García-Campelo R, Martí Blanco C, Diz-Taín MP, López-Brea M, Moreno-Vega AL, León-Mateos L, Oramás J, Gutiérrez-Calderón V, Majem M, Sánchez-Hernández A, Aguado C, Alvarez-Cabellos R, Massutí B, Moreno A, Fírvida-Pérez JL, Valdivia J, González-Cordero M, Zafra-Poves M, Dómine M, Garcia-Navalon FJ, Villanueva N, Provencio M, Juan-Vidal O, Rivas-Corredor C, Olmedo García ME, Palmero R, López-Castro R, Carcereny E, Lechuga JL, Domínguez M, Callejo Á, Paz-Ares L.

    Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial

    LUNG CANCER . 209: 108763-108763.

    [doi:10.1016/j.lungcan.2025.108763]

  • Rosas Cancio-Suárez M, Moreno E, Del Valle Rubido C, Salvador M, Moreno A, Luna L, Díaz-García C, Tapia C, Del Amo A, Moreno S, Sánchez-Conde M, Serrano-Villar S.

    Cervical microbiota diversity and functional shifts in the development of cervical high-grade squamous intraepithelial lesions

    Frontiers in Medicine . 12: 1615571-1615571.

    [doi:10.3389/fmed.2025.1615571]

  • Buzón L, Bernardino JI, Galindo Puerto MJ, Martín-Torres J, Alemán Valls MR, Torralba González de Suso M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello Úbeda A, Pedrero-Tomé R, Crusells Canales MJ, Calzado Isbert S, Aguilera García M, Hidalgo Tenorio C, Morano L, Vinuesa García D, de Andrés David C, Bernal Morell E, Martínez Álvarez RM, Cabello Clotet N, Tiraboschi J, Gimeno García A, Vivancos MJ, Troya J.

    Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.

    AIDS . 40(4): 414-427. Nº de citas: 5

    [doi:10.1097/QAD.0000000000004388]

  • Jover F, Martínez-Sanz J, Antela A, López-Cavanillas M, Viguera-Moreno M, González-Rodríguez P, Domingo P.

    Is less truly more? - reassessing antiretroviral efficacy - a safety analysis for HIV patients switching from triple to double regimens with integrase inhibitors: A systematic review and meta-analysis

    MEDICINE . 104(42): .

    [doi:10.1097/MD.0000000000045152]

  • Labiod N, Sánchez-Seco MP, Goikoetxea J, Zurita ND, Norman FF, Martínez MM, Alonso PA, Hernández-Betancor A, Sempere-Alcocer MA, Moure Z, Ocete MD, Vicente MR, de la Calle-Prieto F, Gallego M, Domingo LC, Galán JC, Camprubí-Ferrer D, Meilán C, Perez-Hernandez I, Cabezón I, Hernández FJ, Bernal E, Vázquez A.

    Case series of Oropouche fever among travellers returning from Cuba to Spain, 2024

    Eurosurveillance . 30(41): . Nº de citas: 6

    [doi:10.2807/1560-7917.ES.2025.30.41.2400719]

  • Pérez-Valero I, Mata DC, Espejo AC, Gallo M, de Morales AGG, Fanciulli C, Carbonero LM, Isbert SC, Gutiérrez CH, Asensi V, Juarez AR, Rivero A.

    Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With Human Immunodeficiency Virus Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort-The ACTUAS II Study

    CLINICAL INFECTIOUS DISEASES . 81(4): 93-101. Nº de citas: 2

    [doi:10.1093/cid/ciaf162]